Home » Topics » BioWorld Science

BioWorld Science
RSS

Kinnate Biopharma synthesizes new CDK inhibitors

Feb. 11, 2021

Korean investigators disclose tubulin polymerization inhibitors

Feb. 11, 2021

Silverback Therapeutics patents TGFR-1 inhibitors

Feb. 11, 2021

Updates on clinical development of the Parkinson's disease candidate YTX-7739

Feb. 11, 2021

Panbela provides updates regarding its development of SBP-101

Feb. 11, 2021

mNb6-tri, a novel potent trivalent nanobody against SARS-CoV-2

Feb. 11, 2021

Enrollment ongoing in phase III study of LNP-023 in adults with PNH with residual anemia

Feb. 11, 2021

Janssen initiates phase II portion of first-in-human trial of talquetamab

Feb. 11, 2021

Careful with that BBB

Feb. 11, 2021

NanoViricides reports animal safety data on broad-spectrum anti-coronavirus drug candidate NV-CoV-2

Feb. 11, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...